17-63931077-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000626.4(CD79B):c.118+258G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.231 in 537,484 control chromosomes in the GnomAD database, including 15,780 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.25 ( 5168 hom., cov: 32)
Exomes 𝑓: 0.22 ( 10612 hom. )
Consequence
CD79B
NM_000626.4 intron
NM_000626.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.841
Genes affected
CD79B (HGNC:1699): (CD79b molecule) The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-beta protein of the B-cell antigen component. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 17-63931077-C-T is Benign according to our data. Variant chr17-63931077-C-T is described in ClinVar as [Benign]. Clinvar id is 1291751.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.323 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD79B | NM_000626.4 | c.118+258G>A | intron_variant | Intron 2 of 5 | ENST00000006750.8 | NP_000617.1 | ||
CD79B | NM_001039933.3 | c.121+258G>A | intron_variant | Intron 2 of 5 | NP_001035022.1 | |||
CD79B | NM_001329050.2 | c.121+258G>A | intron_variant | Intron 2 of 4 | NP_001315979.1 | |||
CD79B | NM_021602.4 | c.118+258G>A | intron_variant | Intron 2 of 4 | NP_067613.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD79B | ENST00000006750.8 | c.118+258G>A | intron_variant | Intron 2 of 5 | 1 | NM_000626.4 | ENSP00000006750.4 | |||
ENSG00000285947 | ENST00000647774.1 | c.49+258G>A | intron_variant | Intron 1 of 7 | ENSP00000497443.1 |
Frequencies
GnomAD3 genomes AF: 0.254 AC: 38587AN: 151954Hom.: 5174 Cov.: 32
GnomAD3 genomes
AF:
AC:
38587
AN:
151954
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.223 AC: 85787AN: 385412Hom.: 10612 Cov.: 2 AF XY: 0.219 AC XY: 44806AN XY: 204262
GnomAD4 exome
AF:
AC:
85787
AN:
385412
Hom.:
Cov.:
2
AF XY:
AC XY:
44806
AN XY:
204262
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.254 AC: 38590AN: 152072Hom.: 5168 Cov.: 32 AF XY: 0.247 AC XY: 18355AN XY: 74352
GnomAD4 genome
AF:
AC:
38590
AN:
152072
Hom.:
Cov.:
32
AF XY:
AC XY:
18355
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
347
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Jun 18, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at